Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × mogamulizumab × Lymphoid × Clear all

Phase

Phase 2 10 Phase 1 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mycosis Fungoides 1

Interventions

Cyclophosphamide 17 fludarabine 9 Rituximab 8 Vincristine 6 Etoposide 5 Doxorubicin 5 pembrolizumab 4 Radiotherapy 4 Prednisone 4 Methotrexate 4 Immunotherapy, Adoptive 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Dexamethasone 4 venetoclax 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Ifosfamide 3 68Ga-pentixafor 3 ibrutinib 2 daratumumab 2 Transplantation 2 Sirolimus 2 Radiation 2 Phototherapy 2 Melphalan 2 Immunohistochemistry 2 Imiquimod 2 Exercise 2 Decitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06235281 2026-02-27

PLIGHT

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Suspended

Mycosis Fungoides

Data powered by HemOnc (CC BY 4.0) Colophon ⚡